Sodium dichloroacetate

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Sodium dichloroacetate

CAS No. : 2156-56-1

MCE 国际站：Sodium dichloroacetate

产品活性：Sodium dichloroacetate 是癌细胞线粒体中的一种代谢调节剂，具有抗癌活性。Sodium dichloroacetate 抑制 PDHK，从而导致肿瘤微环境中的乳酸减少。Sodium dichloroacetate 增加活性氧 (ROS) 的产生并促进癌细胞凋亡，还可作为 NKCC 抑制剂。

研究领域：Metabolic Enzyme/Protease  |  NF-κB  |  Immunology/Inflammation  |  Membrane Transporter/Ion Channel  |  Apoptosis

作用靶点：PDHK  |  Reactive Oxygen Species  |  NKCC  |  Apoptosis

In Vitro: Sodium dichloroacetate increases ROS generation in mitochondria. Sodium dichloroacetate affects cell growth and viability through the ROS production increase derived from the promotion of oxidative metabolism. The effects of Sodium dichloroacetate on multiple myeloma cell viability, cell cycle arrest, and apoptotic cell death were associated with pyruvate dehydrogenase kinases (PDK) inhibition, restored pyruvate dehydrogenase (PDH) activity, and the promotion of oxidative metabolism in association with increased intracellular ROS production which depends on the Sodium dichloroacetate dose. The Sodium dichloroacetate effects cooperated with C I inhibition promoting the oxidative stress in rat VM-M3 glioblastoma cells. Increased ROS levels in Sodium dichloroacetate-treated cancer cells are related to the induction of apoptosis associated with the increased cytochrome c expression. Sodium dichloroacetate causes ROS-dependent T-cell differentiation.

In Vivo: The NKCC1 RNA expression levels in Sodium dichloroacetate-treated gonad-intact and castrated males are significantly decreased, and no such effect is determined in the gonad-intact and castrated female Sodium dichloroacetate-treated rats.
A single Sodium dichloroacetate dose causes a significantly higher 24 h diuresis in Wistar male rats, and the increased diuresis is related to NKCC2 inhibition. The NKCC2 is more abundant in kidneys of intact females compared to intact males, with a greater transporter density in Sprague-Dawley female rats.
The oral Sodium dichloroacetate bioavailability in naïve male rats dosed 5, 20 and 100 mg/kg is significantly lower than in GSTζ-depleted ones (10%, 13%, 81% and 31%, 75%, 100%, respectively). The liver extraction of Sodium dichloroacetate in the GSTζ-depleted rats has linear kinetics, but it decreases with the metabolism saturation at higher doses.

相关产品：Apoptosis Compound Library  |  Drug Repurposing Compound Library  |  Anti-Aging Compound Library  |  Antioxidants Compound Library  |  NF-κB Signaling Compound Library  |  Kinase Inhibitor Library  |  Clinical Compound Library  |  Oxygen Sensing Compound Library  |  Clinical Compound Library Plus  |  Glycolysis Compound Library  |  Ferroptosis Compound Library  |  Anti-Cancer Compound Library  |  Metabolism/Protease Compound Library  |  Drug Repurposing Compound Library Plus  |  Bioactive Compound Library Plus  |  Membrane Transporter/Ion Channel Compound Library  |  Immunology/Inflammation Compound Library  |  FDA Approved & Pharmacopeial Drug Library  |  Pyroptosis Compound Library  |  MG-132  |  LY294002  |  Doxorubicin hydrochloride  |  Bafilomycin A1  |  Paclitaxel  |  Y-27632 dihydrochloride  |  Sorafenib  |  SP600125  |  Staurosporine  |  H2DCFDA  |  Angiotensin II human  |  5-Fluorouracil  |  Trametinib  |  Acetylcysteine  |  MK-2206 dihydrochloride  |  Bortezomib  |  Tamoxifen  |  Gemcitabine  |  Pexidartinib  |  2-Deoxy-D-glucose  |  Temozolomide  |  Ruxolitinib  |  Verteporfin  |  Decitabine  |  BAY 11-7082  |  Mdivi-1  |  Etoposide  |  DAPT  |  Dasatinib

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供最全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药专利收录了MCE客户的科研成果；
•   专业团队跟踪制药及生命科学研究进展，为您提供全球活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。